Actively Recruiting
Pilot Study of Percutaneous Correction of Hallux Valgus
Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-04
40
Participants Needed
1
Research Sites
253 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a pilot study with a randomized controlled design.
CONDITIONS
Official Title
Pilot Study of Percutaneous Correction of Hallux Valgus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of both sexes with adult hallux valgus needing corrective surgery
- Hallux valgus angle (HVA) between 20° and 40°
- Intermetatarsal angle (IMA) between 10° and 20°
You will not qualify if you...
- Instability of the first metatarsophalangeal joint
- Severe structural foot or lower limb problems or other foot pathologies
- Need for additional surgical procedures
- Severe vascular or neurological systemic diseases
- Systemic diseases that may affect bone healing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40136
Actively Recruiting
Research Team
L
Lisa Berti, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here